Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Terns Pharmaceuticals, Inc.

Terns Pharmaceuticals, Inc. (TERN) Stock Overview

Explore Terns Pharmaceuticals, Inc.’s financial performance, market position, analyst ratings, and future outlook.

TERN●NASDAQ
HealthcareBiotechnology
$52.95
$0.02(0.03%)
U.S. Market is Open · 14:09

Terns Pharmaceuticals, Inc. (TERN)

Meyka AI Score

Z

Key Financials

Market Cap4.8B
P/E Ratio-51.41
EPS (TTM)$-1.03
ROE-0.20%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 Months$72.19
1 Year Target$39.21

TERN Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Terns Pharmaceuticals, Inc. (NASDAQ: TERN) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Terns Pharmaceuticals, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of TERN on the NASDAQ shows an RSI of 0.00, suggesting the stock is in a an oversold condition. Our forecasting models predict a 12-month price target of $39.21 for the NASDAQ listing.

Key metrics behind Terns Pharmaceuticals, Inc.'s NASDAQ-traded stock include a P/E ratio of -51.41 and a market capitalization of 4.8B. Combined with our AI analysis, these give both institutional and retail investors a clear view of TERN on the NASDAQ.

Price Performance (NASDAQ: TERN)

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
13.82%
6-Month Change
17.67%
Year-to-Date (YTD) Change
31.06%
1-Year Change
1220.45%
3-Year Change
349.87%
5-Year Change
247.21%
All-Time (Max) Change
187.93%

Contact Information

https://www.ternspharma.com
650 525 5535
1065 East Hillsdale Boulevard, Foster City, CA, 94404

Company Facts

590 Employees
IPO DateFeb 5, 2021
CountryUS

Frequently Asked Questions